Cas 896729-07-0,3-(4'-hydroxymethylphenyl)-4-(4'-methylsulfonyl-phenyl)-1-propyl-3-pyrrolin-2-one

896729-07-0

Post Buying Request

Basic information

Product Name: 3-(4'-hydroxymethylphenyl)-4-(4'-methylsulfonyl-phenyl)-1-propyl-3-pyrrolin-2-one
Synonyms: 3-(4'-hydroxymethylphenyl)-4-(4'-methylsulfonyl-phenyl)-1-propyl-3-pyrrolin-2-one
CAS NO:896729-07-0
Molecular Formula:
Molecular Weight: 385.484
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: 653.8±55.0 °C(Predicted)
Flash Point: N/A
Appearance: N/A
Density: 1.269±0.06 g/cm3(Predicted)
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-(4'-hydroxymethylphenyl)-4-(4'-methylsulfonyl-phenyl)-1-propyl-3-pyrrolin-2-one(CAS DataBase Reference)
NIST Chemistry Reference: 3-(4'-hydroxymethylphenyl)-4-(4'-methylsulfonyl-phenyl)-1-propyl-3-pyrrolin-2-one(896729-07-0)
EPA Substance Registry System: 3-(4'-hydroxymethylphenyl)-4-(4'-methylsulfonyl-phenyl)-1-propyl-3-pyrrolin-2-one(896729-07-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 896729-07-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

896729-07-0 Suppliers

Recommended suppliers

896729-07-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 896729-07-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,6,7,2 and 9 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 896729-07:
(8*8)+(7*9)+(6*6)+(5*7)+(4*2)+(3*9)+(2*0)+(1*7)=240
240 % 10 = 0
So 896729-07-0 is a valid CAS Registry Number.

896729-07-0Upstream product

1138324-54-5 C₂₃H₂₇NO₆S

896729-07-0Downstream Products

896729-07-0Relevant academic research and scientific papers

Synthesis and anti-inflammatory activity of the major metabolites of imrecoxib

Feng, Zhiqiang,Chu, Fengming,Guo, Zongru,Sun, Piaoyang

scheme or table, p. 2270 - 2272 (2009/12/03)

We have developed a novel and moderately selective COX-2 inhibitor, imrecoxib, as a new anti-inflammatory drug. We describe herein the preparation of the major metabolites M2 and M4 of imrecoxib, as well as the in vitro and in vivo activities of the two c

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 896729-07-0